{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:51:06Z","timestamp":1791899466249,"version":"4.3.4"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n While home-based self-sampling for cervical cancer screening is an evidence-based strategy proven to increase screening access and uptake, it is not currently recommended in the US despite recent Food and Drug Administration approval of the first at-home self-sampling device. Little nationally representative research has examined preference for and drivers of home-based self-sampling over clinic-based testing (the standard of care).<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess women\u2019s perspectives about, reasons for considering, and factors associated with preferring at-home self-sampling for cervical cancer screening.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This population-based cross-sectional study used data from the 2024 Health Interview National Trends Survey (HINTS 7), a nationally representative survey of the civilian, noninstitutionalized US adult population offered between March and September 2024. Respondents included in this study were individuals aged between 21 and 65 years who were eligible for cervical cancer screening per the US Preventive Services Task Force guidelines and who self-reported their gender identity. Respondents who indicated not needing cervical cancer screening or who did not report their preference for any screening modality (home-based self-sampling or clinician-collected sampling) were excluded. Data were analyzed from May 12 to 25, 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Age, race and ethnicity, income, educational level, sexual orientation, marital status, health insurance, urbanicity of residence, trust in the health care system, past-year number of visits to a health care practitioner, and prior experience of discrimination or prejudice when getting medical care.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The main outcome was preference for at-home vaginal self-sampling over clinic-based testing, measured using the HINTS 7 question, \u201cIf you had choice, how would you prefer to do the cervical cancer screening test?\u201d Responses were: preference to have a health care practitioner do the test in his or her office, preference to self-collect specimen for the test at home, not knowing which option to choose, and not applicable. Weights were assigned to improve representativeness of the general US adult population. The proportion of individuals who reported preferring either screening modality was estimated using weighted percentages. Survey-weighted odds ratios (ORs), adjusted for covariates, were calculated to identify factors associated with preference for at-home self-sampling.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among the 2300 women included (mean [SD] age, 45.5 [29.2] years), most were married or living as married (weighted percentage, 58.2% [95% CI, 56.5%-60.0%]), health insured (91.9%; 95% CI, 90.7%-93.1%), and educated up to some college (61.6%; 95% CI, 60.1%-63.0%). Overall, 462 (20.4%; 95% CI, 17.4%-23.4%) preferred at-home self-sampling, 1402 (60.8%; 95% CI, 57.2%-64.4%) preferred clinic-based testing, and 436 (18.8%; 95% CI, 15.5%-22.1%) were uncertain about their choice. Non-Hispanic Black respondents (adjusted OR [AOR], 0.45; 95% CI, 0.21-0.96) had lower odds of preferring at-home self-sampling compared with non-Hispanic White individuals. Women who had experienced prejudice or discrimination when getting medical care had higher odds (AOR, 1.94; 95% CI, 1.16-3.22) of preferring at-home self-sampling. The most commonly self-reported reasons for preferring at-home self-sampling were privacy (54.9%; 95% CI, 49.8%-60.0%), time constraints (35.1%; 95% CI, 29.0%-41.2%), and fear of embarrassment (33.4%; 95% CI, 28.0%-38.8%).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study, marginalized populations, individuals with low income, and individuals who do not trust the health care system were more likely to prefer at-home self-sampling for cervical cancer screening or not know which option to choose. To address cervical cancer inequities and increase screening uptake, the findings suggest US guidelines should incorporate home-based self-sampling as an alternative to clinic-based testing, women\u2019s education and empowerment should be enhanced, and tailored interventions focusing on high-risk groups are needed to increase awareness and self-confidence in performing home-based self-sampling.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.58841","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:30:34Z","timestamp":1770395434000},"page":"e2558841","source":"Crossref","is-referenced-by-count":3,"title":["Women\u2019s Preferences for Home-Based Self-Sampling or Clinic-Based Testing for Cervical Cancer Screening"],"prefix":"10.1001","volume":"9","author":[{"given":"Jo\u00ebl","family":"Fokom Domgue","sequence":"first","affiliation":[{"name":"Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monalisa","family":"Chandra","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olajumoke","family":"Oladoyin","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Behavioral Sciences, School of Public Health, The University of Texas Health Science Center at Houston (UTHealth)"},{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston (UTHealth)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Shete","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"6","key":"zoi251563r5","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/cncr.30507","article-title":"Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.","volume":"123","author":"Beavis","year":"2017","journal-title":"Cancer"},{"issue":"9","key":"zoi251563r6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/jnci\/dji115","article-title":"Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.","volume":"97","author":"Leyden","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"zoi251563r8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial.","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"zoi251563r9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"issue":"7","key":"zoi251563r10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"21","key":"zoi251563r11","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1001\/jama.2021.13448","article-title":"Cervical cancer screening guideline for individuals at average risk.","volume":"326","author":"Chor","year":"2021","journal-title":"JAMA"},{"key":"zoi251563r12","doi-asserted-by":"publisher","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"issue":"2","key":"zoi251563r13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"zoi251563r14","first-page":"31","article-title":"Predictors of cervical cancer screening adherence in the United States: a systematic review.","volume":"5","author":"Limmer","year":"2014","journal-title":"J Adv Pract Oncol"},{"key":"zoi251563r15","doi-asserted-by":"publisher","DOI":"10.5888\/pcd13.160225","article-title":"Understanding barriers to cervical cancer screening in women with access to care, behavioral risk factor surveillance system, 2014.","volume":"13","author":"Crawford","year":"2016","journal-title":"Prev Chronic Dis"},{"issue":"44","key":"zoi251563r16","first-page":"1004","article-title":"Vital signs: cervical cancer incidence, mortality, and screening\u2014United States, 2007-2012.","volume":"63","author":"Benard","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"zoi251563r17","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ejca.2015.07.006","article-title":"Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials.","volume":"51","author":"Verdoodt","year":"2015","journal-title":"Eur J Cancer"},{"key":"zoi251563r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2019.07.003","article-title":"Corrigendum to \u201crationale and design of the HOME trial: a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a US healthcare system\u201d [Contemp. Clin. Trials 64 (2018) 77-87].","volume":"84","author":"Winer","year":"2019","journal-title":"Contemp Clin Trials"},{"issue":"6","key":"zoi251563r19","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/S2468-2667(23)00076-2","article-title":"Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.","volume":"8","author":"Pretsch","year":"2023","journal-title":"Lancet Public Health"},{"issue":"3","key":"zoi251563r21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.amepre.2023.10.020","article-title":"Self-sampling for human papillomavirus testing: acceptability in a US safety net health system.","volume":"66","author":"Parker","year":"2024","journal-title":"Am J Prev Med"},{"issue":"20","key":"zoi251563r22","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1001\/jama.2023.21471","article-title":"Strategies to increase cervical cancer screening with mailed human papillomavirus self-sampling kits: a randomized clinical trial.","volume":"330","author":"Winer","year":"2023","journal-title":"JAMA"},{"key":"zoi251563r23","doi-asserted-by":"publisher","DOI":"10.1200\/GO.24.00005","article-title":"Culturally competent education and human papillomavirus self-sampling achieves Healthy People 2030 cervical screening target among low-income non-Hispanic Black and Hispanic women.","volume":"10","author":"Shastri","year":"2024","journal-title":"JCO Glob Oncol"},{"issue":"5","key":"zoi251563r24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.11081","article-title":"Clinical validation of a vaginal cervical cancer screening self-collection method for at-home use: a nonrandomized clinical trial.","volume":"8","author":"Fitzpatrick","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi251563r28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/109019818801500401","article-title":"An ecological perspective on health promotion programs.","volume":"15","author":"McLeroy","year":"1988","journal-title":"Health Educ Q"},{"issue":"6","key":"zoi251563r31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.17094","article-title":"Cervical cancer screening rates among rural and urban females, from 2019 to 2022.","volume":"7","author":"Borders","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi251563r32","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1016\/j.ajog.2025.02.008","article-title":"Adherence to cervical cancer screening among sexual and racial\/ethnic minorities during the COVID-19 pandemic in the United States.","volume":"232","author":"Fokom Domgue","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi251563r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.5058","article-title":"Changes in health care access and preventive health screenings by race and ethnicity.","volume":"5","author":"Alba","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"1","key":"zoi251563r34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.43582","article-title":"Assessment of US Preventive Services Task Force guideline\u2013concordant cervical cancer screening rates and reasons for underscreening by age, race and ethnicity, sexual orientation, rurality, and insurance, 2005 to 2019.","volume":"5","author":"Suk","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi251563r35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.amepre.2023.04.016","article-title":"Racial and ethnic disparities in cervical cancer screening from three US healthcare settings.","volume":"65","author":"Spencer","year":"2023","journal-title":"Am J Prev Med"},{"issue":"2","key":"zoi251563r36","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1080\/03610918.2022.2039396","article-title":"A weighted jackknife approach utilizing linear model based-estimators for clustered data.","volume":"53","author":"Du","year":"2024","journal-title":"Commun Stat Simul Comput"},{"key":"zoi251563r37","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000006147","article-title":"Preferences among US women for cervical cancer screening with self-collected specimens for human papillomavirus testing.","author":"Qin","year":"2025","journal-title":"Obstet Gynecol"},{"issue":"4","key":"zoi251563r38","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/LGT.0000000000000430","article-title":"Preference for human papillomavirus self-collection and Papanicolaou: survey of underscreened women in North Carolina.","volume":"22","author":"Kilfoyle","year":"2018","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"zoi251563r39","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ygyno.2018.04.004","article-title":"Validation of a new HPV self-sampling device for cervical cancer screening: the Cervical and Self-Sample In Screening (CASSIS) study.","volume":"149","author":"El-Zein","year":"2018","journal-title":"Gynecol Oncol"},{"key":"zoi251563r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106900","article-title":"Worldwide use of HPV self-sampling for cervical cancer screening.","volume":"154","author":"Serrano","year":"2022","journal-title":"Prev Med"},{"issue":"11","key":"zoi251563r41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.14729","article-title":"Effect of mailed human papillomavirus test kits vs usual care reminders on cervical cancer screening uptake, precancer detection, and treatment: a randomized clinical trial.","volume":"2","author":"Winer","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi251563r42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.44343","article-title":"Effect of patient characteristics on uptake of screening using a mailed human papillomavirus self-sampling kit: a secondary analysis of a randomized clinical trial.","volume":"5","author":"Winer","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi251563r43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13012-021-01171-7","article-title":"Implementability of healthcare interventions: an overview of reviews and development of a conceptual framework.","volume":"17","author":"Klaic","year":"2022","journal-title":"Implement Sci"},{"key":"zoi251563r44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2024.100331","article-title":"Acceptability of HPV self-collection: a qualitative study of Black women living with type II diabetes and social vulnerability.","volume":"35","author":"Mkuu","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"issue":"8","key":"zoi251563r45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1089\/jwh.2005.14.721","article-title":"Acceptability of self-collection of specimens for HPV DNA testing in an urban population.","volume":"14","author":"Anhang","year":"2005","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"zoi251563r46","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/sti.2004.012047","article-title":"Acceptability of human papillomavirus self testing in female adolescents.","volume":"81","author":"Kahn","year":"2005","journal-title":"Sex Transm Infect"},{"issue":"7","key":"zoi251563r47","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/sextrans-2012-050477","article-title":"A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China.","volume":"88","author":"Guan","year":"2012","journal-title":"Sex Transm Infect"},{"issue":"2","key":"zoi251563r49","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40615-022-01276-9","article-title":"\u201cWe\u2019re not taken seriously\u201d: describing the experiences of perceived discrimination in medical settings for Black women.","volume":"10","author":"Washington","year":"2023","journal-title":"J Racial Ethn Health Disparities"},{"issue":"2","key":"zoi251563r50","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1089\/jwh.2013.4328","article-title":"Perceived discrimination is associated with reduced breast and cervical cancer screening: the Study of Women\u2019s Health Across the Nation (SWAN).","volume":"23","author":"Jacobs","year":"2014","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"zoi251563r52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.8886","article-title":"Sexual orientation and cervical cancer screening among cisgender women.","volume":"7","author":"Baumann","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi251563r53","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1186\/s12889-024-19741-x","article-title":"How does online postal self-sampling (OPSS) shape access to testing for sexually transmitted infections (STIs)? a qualitative study of service users.","volume":"24","author":"Spence","year":"2024","journal-title":"BMC Public Health"},{"issue":"12","key":"zoi251563r54","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1245\/s10434-024-15757-0","article-title":"Associations between perceived discrimination, screening mammography, and breast cancer stage at diagnosis: a prospective cohort analysis.","volume":"31","author":"Hernandez","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"zoi251563r55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.dhjo.2017.04.002","article-title":"Association between perceived discrimination and healthcare-seeking behavior in people with a disability.","volume":"11","author":"Moscoso-Porras","year":"2018","journal-title":"Disabil Health J"},{"key":"zoi251563r1","author":"Noone","year":"2018"},{"key":"zoi251563r7","volume-title":"Cervix Cancer Screening","author":"International Agency for Research on Cancer"},{"key":"zoi251563r30","author":"Gorina","year":"2024"},{"key":"zoi251563r2","unstructured":"US National Cancer Institute. Cancer trends progress report: cervical cancer screening. Accessed May 15, 2025. https:\/\/progressreport.cancer.gov\/detection\/cervical_cancer"},{"key":"zoi251563r3","unstructured":"American Cancer Society. Cancer facts and figures, 2024. 2024. Accessed May 15, 2025. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2024\/2024-cancer-facts-and-figures-acs.pdf"},{"key":"zoi251563r4","unstructured":"Surveillance, Epidemiology, and End Results Program. Cancer stat facts: cervical cancer. US National Cancer Institute. Accessed May 15, 2025. https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html"},{"key":"zoi251563r20","unstructured":"FDA approves Teal Health\u2019s Teal Wand\u2014the first and only at-home self-collection device for cervical cancer screening, introducing a comfortable alternative to in-person screening. News release. Teal Health; May 9, 2025. Accessed May 15, 2025. https:\/\/www.getteal.com\/news\/fda-approves-teal-healths-teal-wand-tm---the-first-and-only-at-home-self-collection-device-for-cervical-cancer-screening-introducing-a-comfortable-alternative-to-in-person-screening"},{"key":"zoi251563r25","unstructured":"Health Information National Trends Survey 7 (HINTS 7) methodology report. Accessed November 30, 2025. https:\/\/hints.cancer.gov\/docs\/methodologyreports\/HINTS_7_MethodologyReport.pdf"},{"key":"zoi251563r26","unstructured":"Office for Human Research Protections. Regulations, policy & guidance. US Department of Health and Human Services 2022. Accessed March 3, 2024. https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/index.html"},{"key":"zoi251563r27","unstructured":"EQUATOR (Enhancing the Quality and Transparency of Health Research) Network. Reporting guidelines for main study types. Accessed May 12, 2025. https:\/\/www.equator-network.org\/"},{"key":"zoi251563r29","unstructured":"Herman? JL, Flores? AR. How many adults and youth identify as transgender in the United States? UCLA School of Law Williams Institute. August 2025. Accessed December 10, 2025. https:\/\/williamsinstitute.law.ucla.edu\/publications\/trans-adults-united-states\/"},{"key":"zoi251563r48","unstructured":"Surveillance, Epidemiology, and End Results Program. SEER Incidence Data, 1975-2022. National Cancer Institute. Accessed May 15, 2025. https:\/\/seer.cancer.gov\/data\/"},{"key":"zoi251563r51","unstructured":"World Health Organization. WHO Guideline on Self-Care Interventions for Health and Well-Being, 2022 Revision. 2022. Accessed July 12, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK582359\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2844711\/fokom_domgue_2026_oi_251563_1769708092.81044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:30:37Z","timestamp":1770395437000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2844711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.58841","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]}}}